Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity
S. Vermeire et al., Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity, INFLAMM B D, 6(3), 2000, pp. 165-170
Susceptibility to inflammatory bowel disease (IBD) is significantly determi
ned by genetic factors. Linkage data from genome-wide searches have identif
ied regions on chromosomes 16, 12, 7, and 3. Our goal was to replicate thes
e four regions in a Belgian population of IBD families. Fifty-four IBD fami
lies were studied (47 with Crohn' a disease [CD] and 7 with mixed CD and ul
cerative colitis, containing 79 affected sibpairs (68 CD only, 11 mixed) fo
r the regions previously implicated to chromosomes 16, 12, 7, and 3. In thi
s study, no evidence for linkage was found on any of the four chromosomal r
egions studied for either the whole IBD dataset or the CD subgroup. The mul
tipoint maximum logarithm of odds scores were less than 0.7 for all four re
gions. Exclusion mapping could significantly exclude chromosomes 3, 7, and
12. Despite earlier findings, we could significantly exclude linkage of CD
with previously reported regions on chromosomes 12, 7, and 3, and could not
find evidence for linkage to chromosome 16. It is important to report thes
e findings in light of the genetic heterogeneity of IBD. A genome-wide sear
ch on a larger group of affected siblings is being analyzed to detect other
possible susceptibility loci in the Belgian population.